Dopamine agonist pretreatment alters LSD's electrophysiological action from dopamine agonists to antagonist.
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D003913:Dextroamphetamine / Q000494:pharmacology; D004298:Dopamine / Q000502:physiology*; D018492:Dopamine Antagonists; D004347:Drug Interactions; D005260:Female; D010134:Fenclonine / Q000494:pharmacology; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology*; D008297:Male; D051381:Rats; D013378:Substantia Nigra / Q000187:drug effects
D018492:Dopamine Antagonists; D008238:Lysergic Acid Diethylamide; D001058:Apomorphine; D010134:Fenclonine; D003913:Dextroamphetamine; D004298:Dopamine